Sivaporn Gatechompol, Stephen J. Kerr, Sandra W. Cardoso, Wadzanai Samaneka, Srikanth Tripathy, Sheela Godbole, Manisha Ghate, Cecilia Kanyama, Mulinda Nyirenda, Patcharaphan Sugandhavesa, Andre Machado, Frank Van Leth, Thomas B. Campbell, Susan Swindlells, Anchalee Avihingsanon, Frank Cobelens
(2024).
Monocyte to lymphocyte ratio and hemoglobin level to predict tuberculosis after antiretroviral therapy initiation..
AIDS (London, England).
DOI
Jon C. Emery, Peter J. Dodd, Sayera Banu, Beatrice Frascella, Frances L. Garden, Katherine C. Horton, Shahed Hossain, Irwin Law, Frank van Leth, Guy B. Marks, Hoa Binh Nguyen, Hai Viet Nguyen, Ikushi Onozaki, Maria Imelda D. Quelapio, Alexandra S. Richards, Nabila Shaikh, Edine W. Tiemersma, Richard G. White, Khalequ Zaman, Frank Cobelens, Rein M. G. J. Houben
(2023).
Estimating the contribution of subclinical tuberculosis disease to transmission: An individual patient data analysis from prevalence surveys..
eLife.
DOI
Marjan Molemans, Ria Reis, Fortunate Shabalala, Njabuliso Dlamini, Nelisiwe Masilela, Njabulo Simelane, Christopher Pell, Ariel Chao, Donna Spiegelman, Eva Vernooij, Frank van Leth
(2023).
Reasons for using traditional and complementary care by people living with HIV on antiretroviral therapy and association with interrupted care: a mixed methods study in Eswatini..
BMC complementary medicine and therapies.
DOI
José Domínguez, Martin J. Boeree, Emmanuelle Cambau, Dumitru Chesov, Francesca Conradie, Vivian Cox, Keertan Dheda, Andrii Dudnyk, Maha R. Farhat, Sebastien Gagneux, Martin P. Grobusch, Matthias I. Gröschel, Lorenzo Guglielmetti, Irina Kontsevaya, Berit Lange, Frank van Leth, Christian Lienhardt, Anna M. Mandalakas, Florian P. Maurer, Matthias Merker, Paolo Miotto, Barbara Molina-Moya, Florence Morel, Stefan Niemann, Nicolas Veziris, Andrew Whitelaw, Charles R. Horsburgh, Christoph Lange, TBnet, RESIST-TB networks
(2023).
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement.
The Lancet. Infectious Diseases.
DOI
Michaela Theilmann, Ntombifuthi Ginindza, John Myeni, Sijabulile Dlamini, Bongekile Thobekile Cindzi, Dumezweni Dlamini, Thobile L. Dlamini, Maike Greve, Harsh Vivek Harkare, Mbuso Hleta, Philile Khumalo, Lutz M. Kolbe, Simon Lewin, Lisa-Rufaro Marowa, Sakhile Masuku, Dumsile Mavuso, Marjan Molemans, Nyasatu Ntshalintshali, Nomathemba Nxumalo, Brianna Osetinsky, Christopher Pell, Ria Reis, Fortunate Shabalala, Bongumusa R. Simelane, Lisa Stehr, Fabrizio Tediosi, Frank van Leth, Jan-Walter De Neve, Till Bärnighausen, Pascal Geldsetzer
(2023).
Strengthening primary care for diabetes and hypertension in Eswatini: study protocol for a nationwide cluster-randomized controlled trial.
Trials.
DOI
Yohhei Hamada, Rishi K. Gupta, Matteo Quartagno, Abbie Izzard, Carlos Acuna-Villaorduna, Neus Altet, Roland Diel, Jose Dominguez, Sian Floyd, Amita Gupta, Helena Huerga, Edward C. Jones-López, Aarti Kinikar, Christoph Lange, Frank van Leth, Qiao Liu, Wei Lu, Peng Lu, Irene Latorre Rueda, Leonardo Martinez, Stanley Kimbung Mbandi, Laura Muñoz, Elisabeth Sánchez Padilla, Mandar Paradkar, Thomas Scriba, Martina Sester, Kwame Shanaube, Surendra K. Sharma, Rosa Sloot, Giovanni Sotgiu, Kannan Thiruvengadam, Richa Vashishtha, Ibrahim Abubakar, Molebogeng X. Rangaka
(2023).
Predictive performance of interferon-gamma release assays and the tuberculin skin test for incident tuberculosis: an individual participant data meta-analysis.
EClinicalMedicine.
DOI
Quint Olislagers, Frank van Leth, Fortunate Shabalala, Njabuliso Dlamini, Njabulo Simelane, Nelisiwe Masilela, Gabriela B. Gomez, Christopher Pell, Eva Vernooij, Ria Reis, Marjan Molemans
(2022).
Reasons for, and factors associated with, positive HIV retesting: a cross-sectional study in Eswatini.
AIDS care.
DOI
Lorenzo Guglielmetti, Gunar Günther, Claude Leu, Daniela Cirillo, Raquel Duarte, Alberto L. Garcia-Basteiro, Delia Goletti, Mateja Jankovic, Liga Kuksa, Florian P. Maurer, Frédéric Méchaï, Simon Tiberi, Frank van Leth, Nicolas Veziris, Christoph Lange, Study Group on Mycobacteria of the European Society of Microbiology, European Society of Mycobacteriology (ESM), European Respiratory Society (ERS) Infectious Diseases (ESGMYC), and Tuberculosis Network European Trials group (TBnet)
(2022).
Rifapentine access in Europe: growing concerns over key tuberculosis treatment component.
The European Respiratory Journal.
DOI
Jan Heyckendorf, Sebastian Marwitz, Maja Reimann, Korkut Avsar, Andrew DiNardo, Gunar Günther, Michael Hoelscher, Elmira Ibraim, Barbara Kalsdorf, Stefan H. E. Kaufmann, Irina Kontsevaya, Frank van Leth, Anna Maria Mandalakas, Florian P. Maurer, Marius Müller, Dörte Nitschkowski, Ioana D. Olaru, Cristina Popa, Andrea Rachow, Thierry Rolling, Jan Rybniker, Helmut J. F. Salzer, Patricia Sanchez-Carballo, Maren Schuhmann, Dagmar Schaub, Victor Spinu, Isabelle Suárez, Elena Terhalle, Markus Unnewehr, January 3rd Weiner, Torsten Goldmann, Christoph Lange
(2021).
Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model..
The European respiratory journal.
DOI
Rishi K. Gupta, Claire J. Calderwood, Alexei Yavlinsky, Maria Krutikov, Matteo Quartagno, Maximilian C. Aichelburg, Neus Altet, Roland Diel, Claudia C. Dobler, Jose Dominguez, Joseph S. Doyle, Connie Erkens, Steffen Geis, Pranabashis Haldar, Anja M. Hauri, Thomas Hermansen, James C. Johnston, Christoph Lange, Berit Lange, Frank van Leth, Laura Muñoz, Christine Roder, Kamila Romanowski, David Roth, Martina Sester, Rosa Sloot, Giovanni Sotgiu, Gerrit Woltmann, Takashi Yoshiyama, Jean-Pierre Zellweger, Dominik Zenner, Robert W. Aldridge, Andrew Copas, Molebogeng X. Rangaka, Marc Lipman, Mahdad Noursadeghi, Ibrahim Abubakar
(2020).
Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings..
Nature medicine.
DOI
Koukeo Phommasone, Frank van Leth, Mallika Imwong, Gisela Henriques, Tiengkham Pongvongsa, Bipin Adhikari, Thomas J. Peto, Cholrawee Promnarate, Mehul Dorda, Pasathorn Sirithiranont, Mavuto Mukaka, Pimnara Peerawaranun, Nicholas P. J. Day, Frank Cobelens, Arjen M. Dondorp, Paul N. Newton, Nicholas J. White, Lorenz von Seidlein, Mayfong Mayxay
(2020).
The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDR..
Malaria journal.
DOI
Koukeo Phommasone, Frank van Leth, Thomas J. Peto, Jordi Landier, Thuy-Nhien Nguyen, Rupam Tripura, Tiengkham Pongvongsa, Khin Maung Lwin, Ladda Kajeechiwa, May Myo Thwin, Daniel M. Parker, Jacher Wiladphaingern, Suphak Nosten, Stephane Proux, Chea Nguon, Chan Davoeung, Huy Rekol, Bipin Adhikari, Cholrawee Promnarate, Kesinee Chotivanich, Borimas Hanboonkunupakarn, Podjanee Jittmala, Phaik Yeong Cheah, Mehul Dhorda, Mallika Imwong, Mavuto Mukaka, Pimnara Peerawaranun, Sasithon Pukrittayakamee, Paul N. Newton, Guy E. Thwaites, Nicholas P. J. Day, Mayfong Mayxay, Tran Tinh Hien, Francois H. Nosten, Frank Cobelens, Arjen M. Dondorp, Nicholas J. White, Lorenz von Seidlein
(2020).
Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials..
PloS one.
DOI
C. Lange, R. E. Aarnoutse, J. W. C. Alffenaar, G. Bothamley, F. Brinkmann, J. Costa, D. Chesov, R. van Crevel, M. Dedicoat, J. Dominguez, R. Duarte, H. P. Grobbel, G. Günther, L. Guglielmetti, J. Heyckendorf, A. W. Kay, O. Kirakosyan, O. Kirk, R. A. Koczulla, G. G. Kudriashov, L. Kuksa, F. van Leth, C. Magis-Escurra, A. M. Mandalakas, B. Molina-Moya, C. A. Peloquin, M. Reimann, R. Rumetshofer, H. S. Schaaf, T. Schön, S. Tiberi, J. Valda, P. K. Yablonskii, K. Dheda
(2019).
Management of patients with multidrug-resistant tuberculosis.
The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union Against Tuberculosis and Lung Disease.
DOI
Frank van Leth, Folke Brinkmann, Daniela M. Cirillo, Keertan Dheda, Raquel Duarte, Lorenzo Guglielmetti, Liga Kuksa, Christoph Lange, Carole Mitnick, Alena Skrahina, Khalequ Zaman, Graham Bothamley
(2019).
The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation..
The European respiratory journal.
DOI
Heleen E. Nelissen, Anne L. Cremers, Tochi J. Okwor, Sam Kool, Frank van Leth, Lizzy Brewster, Olalekan Makinde, Rene Gerrets, Marleen E. Hendriks, Constance Schultsz, Akin Osibogun, Anja H. Van’t Hoog
(2018).
Pharmacy-based hypertension care employing mHealth in Lagos, Nigeria - a mixed methods feasibility study..
BMC health services research.
DOI
Gunar Günther, Frank van Leth, Sofia Alexandru, Neus Altet, Korkut Avsar, Didi Bang, Raisa Barbuta, Graham Bothamley, Ana Ciobanu, Valeriu Crudu, Manfred Danilovits, Martin Dedicoat, Raquel Duarte, Gina Gualano, Heinke Kunst, Wiel de Lange, Vaira Leimane, Anne-Marie McLaughlin, Cecile Magis-Escurra, Inge Muylle, Veronika Polcová, Cristina Popa, Rudolf Rumetshofer, Alena Skrahina, Varvara Solodovnikova, Victor Spinu, Simon Tiberi, Piret Viiklepp, Christoph Lange, for TBNET
(2018).
Clinical Management of Multidrug-Resistant Tuberculosis in 16 European Countries.
American Journal of Respiratory and Critical Care Medicine.
DOI
J. Heyckendorf, F. van Leth, K. Avsar, G. Glattki, G. Günther, B. Kalsdorf, M. Müller, I. D. Olaru, T. Rolling, H. J. F. Salzer, M. Schuhmann, E. Terhalle, C. Lange
(2018).
Treatment responses in multidrug-resistant tuberculosis in Germany.
The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union Against Tuberculosis and Lung Disease.
DOI
Jan Heyckendorf, Frank van Leth, Barbara Kalsdorf, Ioana D. Olaru, Gunar Günther, Helmut J. F. Salzer, Elena Terhalle, Thierry Rolling, Georg Glattki, Marius Müller, Maren Schuhmann, Korkut Avsar, Christoph Lange
(2018).
Relapse-free cure from multidrug-resistant tuberculosis in Germany.
The European Respiratory Journal.
DOI
Cecile Magis-Escurra, Gunar Günther, Christoph Lange, Sofia Alexandru, Neus Altet, Korkut Avsar, Didi Bang, Raisa Barbuta, Graham Bothamley, Ana Ciobanu, Valeriu Crudu, Manfred Davilovits, Martin Dedicoat, Raquel Duarte, Gina Gualano, Heike Kunst, Wiel de Lange, Vaira Leimane, Anne-Marie McLaughlin, Inge Muylle, Veronika Polcová, Christina Popa, Rudolf Rumetshofer, Alena Skrahina, Varvara Solodovnikova, Victor Spinu, Simon Tiberi, Piret Viiklepp, Frank van Leth, for TBnet
(2017).
Treatment outcomes of MDR-TB and HIV co-infection in Europe.
The European Respiratory Journal.
DOI
Adhi Kristianto Sugianli, Franciscus Ginting, R. Lia Kusumawati, Emmy Hermiyati Pranggono, Ayodhia Pitaloka Pasaribu, Firza Gronthoud, Suzanne Geerlings, Ida Parwati, Menno D. De Jong, Frank Van Leth, Constance Schultsz
(2017).
Antimicrobial resistance in uropathogens and appropriateness of empirical treatment: a population-based surveillance study in Indonesia.
The Journal of Antimicrobial Chemotherapy.
DOI
Martin J. Dedicoat, Gunar Günther, Valeriu Crudu, Raquel Duarte, Gina Gualano, Cecile Magis-Escurra, Rudolf Rumetshofer, Alena Skrahina, Victor Spinu, Simon Tiberi, Piret Viiklepp, Frank van Leth, Christoph Lange, TBNET
(2017).
Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not Cure.
American Journal of Respiratory and Critical Care Medicine.
DOI
Yukari C. Manabe, William Worodria, Frank van Leth, Harriet Mayanja-Kizza, Afsatou Ndama Traore, Josefo Ferro, Nadine Pakker, Matthias Frank, Martin P. Grobusch, Robert Colebunders, Frank Cobelens
(2016).
Prevention of Early Mortality by Presumptive Tuberculosis Therapy Study: An Open Label, Randomized Controlled Trial.
The American Journal of Tropical Medicine and Hygiene.
DOI
Christoph Lange, Raquel Duarte, Mathilde Fréchet-Jachym, Gunar Guenther, Lorenzo Guglielmetti, Ioana D. Olaru, Olena Oliveira, Rudolf Rumetshofer, Nicolas Veziris, Frank van Leth, European MDR-TB database collaboration *
(2016).
Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe.
American Journal of Respiratory and Critical Care Medicine.
DOI
Gunar Günther, Christoph Lange, Sofia Alexandru, Neus Altet, Korkut Avsar, Didi Bang, Raisa Barbuta, Graham Bothamley, Ana Ciobanu, Valeriu Crudu, Manfred Danilovits, Martin Dedicoat, Raquel Duarte, Gina Gualano, Heinke Kunst, Wiel de Lange, Vaira Leimane, Cecile Magis-Escurra, Anne-Marie McLaughlin, Inge Muylle, Veronika Polcová, Christina Popa, Rudolf Rumetshofer, Alena Skrahina, Varvara Solodovnikova, Victor Spinu, Simon Tiberi, Piret Viiklepp, Frank van Leth, for TBNET
(2016).
Treatment Outcomes in Multidrug-Resistant Tuberculosis.
The New England Journal of Medicine.
DOI
M. Senkoro, S. Mfinanga, S. Egwaga, R. Mtandu, D. V. Kamara, D. Basra, L. Fundikira, A. Kahwa, R. Shirima, N. Range, S. G. Hinderaker, F. van Leth
(2016).
Prevalence of pulmonary tuberculosis in adult population of Tanzania: a national survey, 2012.
The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union Against Tuberculosis and Lung Disease.
DOI
G. Günther, F. van Leth, N. Altet, M. Dedicoat, R. Duarte, G. Gualano, H. Kunst, I. Muylle, V. Spinu, S. Tiberi, P. Viiklepp, C. Lange, TBNET
(2015).
Beyond multidrug-resistant tuberculosis in Europe: a TBNET study.
The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union Against Tuberculosis and Lung Disease.
DOI
Gunar Günther, Frank van Leth, Sofia Alexandru, Neus Altet, Korkut Avsar, Didi Bang, Raisa Barbuta, Graham Bothamley, Ana Ciobanu, Valeriu Crudu, Manfred Davilovits, Martin Dedicoat, Raquel Duarte, Gina Gualano, Heinke Kunst, Wiel de Lange, Vaira Leimane, Cecile Magis-Escurra, Anne-Marie McLaughlin, Inge Muylle, Veronika Polcová, Emanuele Pontali, Christina Popa, Rudolf Rumetshofer, Alena Skrahina, Varvara Solodovnikova, Victor Spinu, Simon Tiberi, Piret Viiklepp, Christoph Lange, TBNET
(2015).
Multidrug-resistant tuberculosis in europe, 2010-2011.
Emerging Infectious Diseases.
DOI
Martina Sester, Frank van Leth, Judith Bruchfeld, Dragos Bumbacea, Daniela M. Cirillo, Asli Gorek Dilektasli, José Domínguez, Raquel Duarte, Martin Ernst, Fusun Oner Eyuboglu, Irini Gerogianni, Enrico Girardi, Delia Goletti, Jean-Paul Janssens, Inger Julander, Berit Lange, Irene Latorre, Monica Losi, Roumiana Markova, Alberto Matteelli, Heather Milburn, Pernille Ravn, Theresia Scholman, Paola M. Soccal, Marina Straub, Dirk Wagner, Timo Wolf, Aslihan Yalcin, Christoph Lange, TBNET
(2014).
Risk assessment of tuberculosis in immunocompromised patients. A TBNET study.
American Journal of Respiratory and Critical Care Medicine.
DOI
Christoph Lange, Ibrahim Abubakar, Jan-Willem C Alffenaar, Graham Bothamley, Jose A Caminero, Anna Cristina C Carvalho, Kwok-Chiu Chang, Luigi Codecasa, Ana Correia, Valeriu Crudu, Peter Davies, Martin Dedicoat, Francis Drobniewski, Raquel Duarte, Cordula Ehlers, Connie Erkens, Delia Goletti, Gunar Günther, Elmira Ibraim, Beate Kampmann, Liga Kuksa, Wiel de Lange, Frank van Leth, Jan van Lunzen, Alberto Matteelli, Dick Menzies, Ignacio Monedero, Elvira Richter, Sabine Rüsch-Gerdes, Andreas Sandgren, Anna Scardigli, Alena Skrahina, Enrico Tortoli, Grigory Volchenkov, Dirk Wagner, Marieke J van der Werf, Bhanu Williams, Wing-Wai Yew, Jean-Pierre Zellweger, Daniela Maria Cirillo, for the TBNET
(2014).
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement.
The European respiratory journal.
DOI
Christiaan Mulder, Henk van Deutekom, Erik M Huisman, Sophie Toumanian, Ben F P J Koster, Wieneke Meijer-Veldman, Joke H van Loenhout-Rooyackers, Milo Appel, Sandra M Arend, Martien W Borgdorff, Frank van Leth
(2012).
Role of the QuantiFERON(R)-TB Gold In-Tube assay in screening new immigrants for tuberculosis infection.
The European respiratory journal.
DOI
K Zaman, S Hossain, S Banu, M A Quaiyum, P C Barua, M A Hamid Salim, V Begum, M Akramul Islam, J Ahmed, M Rifat, E Cooreman, M J Van Der Werf, M Borgdorff, F Van Leth
(2012).
Prevalence of smear-positive tuberculosis in persons aged ≥ 15 years in Bangladesh: results from a national survey, 2007-2009.
Epidemiology and infection.
DOI
Shahed Hossain, Mohammad Abdul Quaiyum, Khalequ Zaman, Sayera Banu, Mohammad Ashaque Husain, Mohammad Akramul Islam, Erwin Cooreman, Martien Borgdorff, Knut Lönnroth, Abdul Hamid Salim, Frank van Leth
(2012).
Socio economic position in TB prevalence and access to services: results from a population prevalence survey and a facility-based survey in Bangladesh.
PloS one.
DOI
William Worodria, Marguerite Massinga-Loembe, Doreen Mazakpwe, Kenneth Luzinda, Joris Menten, Frank Van Leth, Harriet Mayanja-Kizza, Luc Kestens, Roy D Mugerwa, Peter Reiss, Robert Colebunders
(2011).
Incidence and Predictors of Mortality and the Effect of Tuberculosis Immune Reconstitution Inflammatory Syndrome in a Cohort of TB/HIV Patients Commencing Antiretroviral Therapy.
Journal of Acquired Immune Deficiency Syndromes (1999).
PDF
DOI
H. Geldenhuys, S. Verver, S. Surtie, M. Hatherill, F. van Leth, F. Kafaar, M. Tameris, W. Kleynhans, K.K. Luabeya, S. Moyo, W. Sikhondze, W. Hanekom, H. Mahomed
(2010).
The tuberculin skin test: a comparison of ruler and calliper readings.
Int J Tuberc Lung Dis.
PDF
T.M. Chonde, D. Basra, S.G. Mfinanga, N. Range, F. Lwilla, R.P. Shirima, A. van Deun, M. Zignol, F.G. Cobelens, S.M. Egwaga, F. van Leth
(2010).
National anti-tuberculosis drug resistance study in Tanzania.
Int J Tuberc Lung Dis.
PDF
T.M. Chonde, B. Doulla, F. van Leth, S.G. Mfinanga, N. Range, F. Lwilla, S.M. Mfaume, A. van Deun, M. Zignol, F.G. Cobelens, S.M. Egwaga
(2008).
Implementation of a national anti-tuberculosis drug resistance survey in Tanzania.
BMC Public Health.
DOI
P. Glaziou, M.J. van der Werf, I. Onozaki, C. Dye, M.W. Borgdorff, C.Y. Chiang, F. Cobelens, D.A. Enarson, P.G. Gopi, T.H. Holtz, S.J. Kim, F. van Leth, W.J. Lew, K. Lonnroth, P. van Maaren, P.R. Narayanan, B. Williams
(2008).
Tuberculosis prevalence surveys: rationale and cost.
Int J Tuberc Lung Dis.
PDF
C. Dye, A. Bassili, A.L. Bierrenbach, J.F. Broekmans, V.K. Chadha, P. Glaziou, P.G. Gopi, M. Hosseini, S.J. Kim, D. Manissero, I. Onozaki, H.L. Rieder, S. Scheele, F. van Leth, M. van der Werf, B.G. Williams
(2008).
Measuring tuberculosis burden, trends, and the impact of control programmes.
Lancet Infect Dis.
DOI
B. Winters, J. Montaner, P.R. Harrigan, B. Gazzard, A. Pozniak, M.D. Miller, S. Emery, F. van Leth, P. Robinson, J.D. Baxter, M. Perez-Elias, D. Castor, S. Hammer, A. Rinehart, H. Vermeiren, E. Van Craenenbroeck, L. Bacheler
(2008).
Determination of Clinically Relevant Cutoffs for HIV-1 Phenotypic Resistance Estimates Through a Combined Analysis of Clinical Trial and Cohort Data.
J Acquir Immune Defic Syndr..
DOI
S. Egwaga, N. Range, F. Lwilla, A. Mkopi, V. Barongo, S. Mtenga, H. Mshinda, F. Cobelens, V. Haag, F. van Leth, P. Grewal
(2008).
Assessment of patient preference in allocation and observation of anti-tuberculosis medication in three districts in Tanzania.
Patient Prefer Adherence.
PDF
V. Bekker, H. Scherpbier, M. Beld, E. Piriou, A. van Breda, J. Lange, F. van Leth, S. Jurriaans, S. Alders, P. Wertheim-van Dillen, D. van Baarle, T. Kuijpers
(2006).
Epstein-Barr virus infects B and non-B lymphocytes in HIV-1-infected children and adolescents.
J Infect Dis.
DOI
F Van Leth, B S Kappelhoff, D Johnson, M H Losso, A Boron-Kaczmarska, M S Saag, J-M Livrozet, D B Hall, J Leith, A D R Huitema, F W Wit, J H Beijnen, J M A Lange
(2006).
Pharmacokinetic parameters of nevirapine and efavirenz in relation to antiretroviral efficacy.
AIDS research and human retroviruses.
PDF
DOI
V. Bekker, C. Bronke, H.J. Scherpbier, J.F. Weel, S. Jurriaans, P.M. Wertheim-van Dillen, F. van Leth, J.M. Lange, K. Tesselaar, D. van Baarle, T.W. Kuijpers
(2005).
Cytomegalovirus rather than HIV triggers the outgrowth of effector CD8+CD45RA+CD27- T cells in HIV-1-infected children.
AIDS.
DOI
F. van Leth, C.B. Huisamen, R. Badaro, B. Vandercam, J. de Wet, J.S. Montaner, D.B. Hall, F.W. Wit, J.M. Lange
(2005).
Plasma HIV-1 RNA decline within the first two weeks of treatment is comparable for nevirapine, efavirenz, or both drugs combined and is not predictive of long-term virologic efficacy: A 2NN substudy.
J Acquir Immune Defic Syndr.
DOI
B.S. Kappelhoff, F. van Leth, P.A. Robinson, T.R. MacGregor, E. Baraldi, F. Montella, D.E. Uip, M.A. Thompson, D.B. Russell, J.M. Lange, J.H. Beijnen, A.D. Huitema
(2005).
Are adverse events of nevirapine and efavirenz related to plasma concentrations?.
Antivir Ther.
PDF
F. van Leth, P. Phanuphak, E. Stroes, B. Gazzard, P. Cahn, F. Raffi, R. Wood, M. Bloch, C. Katlama, J.J. Kastelein, M. Schechter, R.L. Murphy, A. Horban, D.B. Hall, J.M. Lange, P. Reiss
(2004).
Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1.
PLoS Med.
DOI
F. van Leth, P. Phanuphak, K. Ruxrungtham, E. Baraldi, S. Miller, B. Gazzard, P. Cahn, U.G. Lalloo, I.P. van der Westhuizen, D.R. Malan, M.A. Johnson, B.R. Santos, F. Mulcahy, R. Wood, G.C. Levi, G. Reboredo, K. Squires, I. Cassetti, D. Petit, F. Raffi, C. Katlama, R.L. Murphy, A. Horban, J.P. Dam, E. Hassink, R. van Leeuwen, P. Robinson, F.W. Wit, J.M. Lange
(2004).
Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study.
Lancet.
DOI
E. Fontas, F. van Leth, C.A. Sabin, N. Friis-Moller, M. Rickenbach, A. d’Arminio Monforte, O. Kirk, M. Dupon, L. Morfeldt, S. Mateu, K. Petoumenos, W. El-Sadr, S. de Wit, J.D. Lundgren, C. Pradier, P. Reiss
(2004).
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?.
J Infect Dis.
DOI
R. van Leeuwen, C. Katlama, R.L. Murphy, K. Squires, J. Gatell, A. Horban, B. Clotet, S. Staszewski, A. van Eeden, N. Clumeck, M. Moroni, A.T. Pavia, R.E. Schmidt, J. Gonzalez-Lahoz, J. Montaner, F. Antunes, R. Gulick, D. Banhegyi, M. van der Valk, P. Reiss, L. van Weert, F. van Leth, V.A. Johnson, J.P. Sommadossi, J.M. Lange
(2003).
A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients.
AIDS.
DOI
M. van der Valk, J.J. Kastelein, R.L. Murphy, F. van Leth, C. Katlama, A. Horban, M. Glesby, G. Behrens, B. Clotet, R.K. Stellato, H.O. Molhuizen, P. Reiss
(2001).
Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile.
AIDS.
DOI